Background:
Herpes Zoster is a reactivation of a latent infection withVaricella-Zoster Virus (VZV) in a sensory ganglia, often triggered by age-related immunosenescence and immunocompromised state. Maxillary branch of the trigeminal nerve is rarely affected in this infection and approximately seen in 1.7% of the cases [1]. Among risk factors of herpes zoster, vaccines are not common. Recently, cases of VZV reactivation after COVID-19 vaccine have been reported in the litterature [2,3].
Here, we report a case of an herpes zoster involving the maxillary nerve in a 66 year-old immunocompetent female, that appeared 5 days after the first dose of viral vector COVID-19 vaccination.